Cargando…
Serum Afamin a Novel Marker of Increased Hepatic Lipid Content
AIM: Afamin is a liver-produced glycoprotein, a potential early marker of metabolic syndrome. Here we investigated regulation of afamin in a course of the metabolic disease development and in response to 3-month exercise intervention. METHODS: We measured whole-body insulin sensitivity (euglycemic h...
Autores principales: | Kurdiova, Timea, Balaz, Miroslav, Kovanicova, Zuzana, Zemkova, Erika, Kuzma, Martin, Belan, Vitazoslav, Payer, Juraj, Gasperikova, Daniela, Dieplinger, Hans, Ukropcova, Barbara, Ukropec, Jozef |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481912/ https://www.ncbi.nlm.nih.gov/pubmed/34603196 http://dx.doi.org/10.3389/fendo.2021.670425 |
Ejemplares similares
-
Metabolomic Analysis Reveals Changes in Plasma Metabolites in Response to Acute Cold Stress and Their Relationships to Metabolic Health in Cold-Acclimatized Humans
por: Kovaničová, Zuzana, et al.
Publicado: (2021) -
Muscular Power during a Lifting Task Increases after Three Months of Resistance Training in Overweight and Obese Individuals
por: Zemková, Erika, et al.
Publicado: (2017) -
Muscle Carnosine Is Associated with Cardiometabolic Risk Factors in Humans
por: de Courten, Barbora, et al.
Publicado: (2015) -
Afamin: an early predictor of preeclampsia
por: Köninger, Angela, et al.
Publicado: (2018) -
Metabolic Phenotype and Adipose Tissue Inflammation in Patients with Chronic Obstructive Pulmonary Disease
por: Skyba, Peter, et al.
Publicado: (2010)